Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$205K Sell
2,262
-6
-0.3% -$548 0.05% 56
2026
Q1
$233K Buy
2,268
+18
+0.8% +$2.03K 0.07% 47
2025
Q4
$282K Hold
2,250
0.09% 37
2025
Q3
$301K Hold
2,250
0.1% 34
2025
Q2
$306K Hold
2,250
0.1% 31
2025
Q1
$299K Sell
2,250
-414
-16% -$52.7K 0.11% 29
2024
Q4
$301K Sell
2,664
-2
-0.1% -$231 0.12% 24
2024
Q3
$304K Sell
2,666
-83
-3% -$9.1K 0.11% 24
2024
Q2
$286K Buy
2,749
+299
+12% +$31.7K 0.11% 23
2024
Q1
$278K Sell
2,450
-829
-25% -$95K 0.11% 24
2023
Q4
$361K Hold
3,279
0.15% 20
2023
Q3
$318K Buy
+3,279
New +$344K 0.13% 19

Other funds holding ABT

Schiavi & Co's ABT Position: Q2 2026 in Review

Schiavi & Co reduced its Abbott (ABT) stake by 0.26% in Q2 2026, selling an estimated $548 and leaving 2,262 shares worth $205K. The position accounts for 0.05% of the portfolio, ranked #56.

Schiavi & Co first reported a position in ABT in Q3 2023 and has held it in 12 quarters since. The position peaked at $361K in Q4 2023. 2,965 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Schiavi & Co held 2,262 shares of Abbott worth $205K as of Q2 2026.
  • Schiavi & Co sold 6 Abbott shares in Q2 2026, an estimated $548.
  • Abbott made up 0.05% of Schiavi & Co's portfolio in Q2 2026, its #56 holding.
  • Schiavi & Co first reported a position in Abbott in Q3 2023 and has held it in 12 quarters since.
  • Schiavi & Co's Abbott position peaked at $361K in Q4 2023.
  • 2,965 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Schiavi & Co's 13F filing for Q2 2026, filed 10 Aug 2026.